Year-two Follow-up Results of an Observational Study Conducted in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis Patients Treated with Infliximab Biosimilar CT-P13 in a Real-life Setting

被引：0
|
作者：
Fautrel, Bruno [1 ,2 ]
Assing, Maryse [3 ]
Mammar, Nadir [3 ]
Brault, Yves [3 ]
Marotte, Hubert [4 ]
机构：
[1] Sorbonne Univ, Paris, France
[2] Pierre Louis Inst Epidemiol & Publ Hlth, Paris, France
[3] Pfizer, Paris, France
[4] INSERM 1059, St Etienne, France
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1426
引用
收藏
页码：2810 / 2812
页数：3
相关论文
共 50 条
  • [21] Effectiveness and safety of biosimilar infliximab (CT-P13) in a real-life setting in patients with Crohn's disease or ulcerative colitis
    Gheorghe, Cristian
    Svoboda, Pavel
    Mateescu, Bogdan
    JOURNAL OF DRUG ASSESSMENT, 2019, 8 (01) : 129 - 134
  • [22] Opioid use surrounding diagnosis and follow-up in patients with ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis: Results from US claims databases
    Sheahan, Anna
    Anjohrin, Suzanne
    Suruki, Robert
    Stark, Jeffrey L.
    Sloan, Victor S.
    CLINICAL RHEUMATOLOGY, 2024, 43 (06) : 1897 - 1907
  • [23] Striking Discrepancy in the Development of Anti-Drug Antibodies (ADA) in Patients with Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS) in Response to Infliximab (INF) and Its Biosimilar CT-P13
    Braun, Juergen
    Baraliakos, Xenofon
    Kudrin, Alex
    Kim, H.
    Lee, Sang Joon
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (12) : 3538 - 3539
  • [24] A NON-INTERVENTIONAL CLINICAL STUDY EVALUATING THE USE OF GOLIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA), PSORIATIC ARTHRITIS (PSA), AND ANKYLOSING SPONDYLITIS (AS) IN A REAL-LIFE SETTING IN GERMANY
    Krueger, K.
    Burmester, G. R.
    Wassenberg, S.
    Bohl-Buehler, M.
    Thomas, M. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 232 - 232
  • [25] WHAT INTRINSIC AND EXTRINSIC FACTORS AFFECT THE DEVELOPEMENT OF ANTI-DRUG ANTIBODY TO INNOVATOR INFLIXIMAB AND ITS BIOSIMILAR CT-P13 IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Braun, J.
    Park, W.
    Yoo, D. H.
    Suh, C. H.
    Shim, S. C.
    Lee, S. J.
    Lee, S. Y.
    Yun, J. H.
    Kim, S. Y.
    Lee, S. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 463 - 464
  • [26] Real-world safety and efficacy of CT-P13, an infliximab biosimilar, in Japanese rheumatoid arthritis patients naive to or switched from biologics
    Takeuchi, Tsutomu
    Nishikawa, Kiyohiro
    Yamada, Fumika
    Ohshima, Shiro
    Inoue, Makoto
    Yoshioka, Yutaka
    Yamanaka, Hisashi
    MODERN RHEUMATOLOGY, 2022, 32 (04) : 718 - 727
  • [27] Switching from Remicade® to biosimilar CT-P13 in inflammatory bowel disease patients: one year follow-up of a prospective observational cohort study
    Smits, L.
    Grelack, A.
    Drenth, J.
    de Jong, D.
    Boshuizen, R.
    van Esch, A.
    Derikx, L.
    Hoentjen, F.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S419 - S419
  • [28] SWITCHING FROM REMICADEA® TO BIOSIMILAR CT-P13 IN INFLAMMATORY BOWEL DISEASE PATIENTS: ONE YEAR FOLLOW-UP OF A PROSPECTIVE OBSERVATIONAL COHORT STUDY
    Smits, Lisa
    Grelack, Anna
    Drenth, Joost
    De Jong, Dirk J.
    Boshuizen, Ronald
    van Esch, Aura
    Derikx, Lauranne
    Hoentjen, Frank
    GASTROENTEROLOGY, 2017, 152 (05) : S587 - S587
  • [29] SECUKINUMAB RETENTION AND SAFETY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS OR ANKYLOSING SPONDYLITIS: TWO-YEAR INTERIM RESULTS OF THE OBSERVATIONAL SERENA STUDY
    Gaffney, Karl
    Kiltz, Uta
    Sfikakis, Petros
    Gullick, Nicola
    Theodoridou, Athina
    Brandt-Juergens, Jan
    Lespessailles, Eric
    Fang, Juanzhi
    Pournara, Effie
    Schulz, Barbara
    Jagiello, Piotr
    RHEUMATOLOGY, 2022, 61
  • [30] SIMILAR CLINICAL RESPONSES ACHIEVED WITH LOWER VERSUS STANDARD DOSES OF INFLIXIMAB BIOSIMILAR CT-P13 IN PATIENTS WITH ANKYLOSING SPONDYLITIS: REAL-WORLD RESULTS FROM THE RAAS STUDY
    Lee, S. S.
    Kim, T. H.
    Park, W.
    Song, Y. W.
    Suh, C. H.
    Kim, S.
    Yoo, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 716 - 716
12345